217 related articles for article (PubMed ID: 24998103)
41. Uterine leiomyomas: MR imaging-based thermometry and thermal dosimetry during focused ultrasound thermal ablation.
McDannold N; Tempany CM; Fennessy FM; So MJ; Rybicki FJ; Stewart EA; Jolesz FA; Hynynen K
Radiology; 2006 Jul; 240(1):263-72. PubMed ID: 16793983
[TBL] [Abstract][Full Text] [Related]
42. EMAS position statement: management of uterine fibroids.
Pérez-López FR; Ornat L; Ceausu I; Depypere H; Erel CT; Lambrinoudaki I; Schenck-Gustafsson K; Simoncini T; Tremollieres F; Rees M;
Maturitas; 2014 Sep; 79(1):106-16. PubMed ID: 24975954
[TBL] [Abstract][Full Text] [Related]
43. Long-term outcome of uterine artery embolization for symptomatic uterine leiomyomas.
Lohle PN; Voogt MJ; De Vries J; Smeets AJ; Vervest HA; Lampmann LE; Boekkooi PF
J Vasc Interv Radiol; 2008 Mar; 19(3):319-26. PubMed ID: 18295689
[TBL] [Abstract][Full Text] [Related]
44. Uterine Fibroids: Correlation of T2 Signal Intensity with Semiquantitative Perfusion MR Parameters in Patients Screened for MR-guided High-Intensity Focused Ultrasound Ablation.
Kim YS; Lee JW; Choi CH; Kim BG; Bae DS; Rhim H; Lim HK
Radiology; 2016 Mar; 278(3):925-35. PubMed ID: 26313526
[TBL] [Abstract][Full Text] [Related]
45. Long-term outcomes of uterine artery embolization using gelatin sponge particles alone for symptomatic fibroids.
Katsumori T; Kasahara T; Akazawa K
AJR Am J Roentgenol; 2006 Mar; 186(3):848-54. PubMed ID: 16498120
[TBL] [Abstract][Full Text] [Related]
46. Safety and therapeutic efficacy of complete or near-complete ablation of symptomatic uterine fibroid tumors by MR imaging-guided high-intensity focused US therapy.
Park MJ; Kim YS; Rhim H; Lim HK
J Vasc Interv Radiol; 2014 Feb; 25(2):231-9. PubMed ID: 24360886
[TBL] [Abstract][Full Text] [Related]
47. Clinical failure after uterine artery embolization: evaluation of patient and MR imaging characteristics.
Toor SS; Tan KT; Simons ME; Rajan DK; Beecroft JR; Hayeems E; Sniderman KW
J Vasc Interv Radiol; 2008 May; 19(5):662-7. PubMed ID: 18440453
[TBL] [Abstract][Full Text] [Related]
48. Uterine artery embolization for symptomatic adenomyosis with or without uterine leiomyomas with the use of calibrated tris-acryl gelatin microspheres: midterm clinical and MR imaging follow-up.
Lohle PN; De Vries J; Klazen CA; Boekkooi PF; Vervest HA; Smeets AJ; Lampmann LE; Kroencke TJ
J Vasc Interv Radiol; 2007 Jul; 18(7):835-41. PubMed ID: 17609441
[TBL] [Abstract][Full Text] [Related]
49. Uterine artery embolization using gelatin sponge particles alone for symptomatic uterine fibroids: midterm results.
Katsumori T; Nakajima K; Mihara T; Tokuhiro M
AJR Am J Roentgenol; 2002 Jan; 178(1):135-9. PubMed ID: 11756107
[TBL] [Abstract][Full Text] [Related]
50. Gadolinium-enhanced MR imaging in the evaluation of uterine fibroids treated with uterine artery embolization.
Katsumori T; Nakajima K; Tokuhiro M
AJR Am J Roentgenol; 2001 Aug; 177(2):303-7. PubMed ID: 11461850
[TBL] [Abstract][Full Text] [Related]
51. Clinical improvement and shrinkage of uterine fibroids after thermal ablation by magnetic resonance-guided focused ultrasound surgery.
Rabinovici J; Inbar Y; Revel A; Zalel Y; Gomori JM; Itzchak Y; Schiff E; Yagel S
Ultrasound Obstet Gynecol; 2007 Oct; 30(5):771-7. PubMed ID: 17899577
[TBL] [Abstract][Full Text] [Related]
52. Comparison of four embolic materials at uterine artery embolization by using postprocedural MR imaging enhancement.
Abramowitz SD; Israel GM; McCarthy SM; Pollak JS; White RI; Tal MG
Radiology; 2009 Feb; 250(2):482-7. PubMed ID: 19188316
[TBL] [Abstract][Full Text] [Related]
53. Expulsion of dominant submucosal fibroids after uterine artery embolization.
Radeleff B; Eiers M; Bellemann N; Ramsauer S; Rimbach S; Kauczor HU; Richter GM
Eur J Radiol; 2010 Jul; 75(1):e57-63. PubMed ID: 19692192
[TBL] [Abstract][Full Text] [Related]
54. Diffusion-weighted imaging for evaluation of uterine arterial embolization of fibroids.
Faye N; Pellerin O; Thiam R; Chammings F; Brisa M; Marques E; Cuénod CA; Sapoval M; Fournier LS
Magn Reson Med; 2013 Dec; 70(6):1739-47. PubMed ID: 23440651
[TBL] [Abstract][Full Text] [Related]
55. Modern management of uterine fibroids.
Levy BS
Acta Obstet Gynecol Scand; 2008; 87(8):812-23. PubMed ID: 18607823
[TBL] [Abstract][Full Text] [Related]
56. Targeted vessel ablation for more efficient magnetic resonance-guided high-intensity focused ultrasound ablation of uterine fibroids.
Voogt MJ; van Stralen M; Ikink ME; Deckers R; Vincken KL; Bartels LW; Mali WP; van den Bosch MA
Cardiovasc Intervent Radiol; 2012 Oct; 35(5):1205-10. PubMed ID: 22146977
[TBL] [Abstract][Full Text] [Related]
57. Use of medical, surgical and complementary treatments among women with fibroids.
Jacoby VL; Jacoby A; Learman LA; Schembri M; Gregorich SE; Jackson R; Kuppermann M
Eur J Obstet Gynecol Reprod Biol; 2014 Nov; 182():220-5. PubMed ID: 25445104
[TBL] [Abstract][Full Text] [Related]
58. Reintervention risk and quality of life outcomes after uterine-sparing interventions for fibroids: a systematic review and meta-analysis.
Sandberg EM; Tummers FHMP; Cohen SL; van den Haak L; Dekkers OM; Jansen FW
Fertil Steril; 2018 Apr; 109(4):698-707.e1. PubMed ID: 29653718
[TBL] [Abstract][Full Text] [Related]
59. Uterine artery embolization for leiomyomas: percentage of infarction predicts clinical outcome.
Kroencke TJ; Scheurig C; Poellinger A; Gronewold M; Hamm B
Radiology; 2010 Jun; 255(3):834-41. PubMed ID: 20392986
[TBL] [Abstract][Full Text] [Related]
60. Uterine fibroid tumors: long-term MR imaging outcome after embolization.
Pelage JP; Guaou NG; Jha RC; Ascher SM; Spies JB
Radiology; 2004 Mar; 230(3):803-9. PubMed ID: 14990844
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
